Intercept Pharmaceuticals Settles Ocaliva Patent Litigation Case, With Dr Reddy's

Intercept Pharmaceuticals Inc has said it entered into a settlement agreement with Dr Reddy's Laboratories resolving the previously disclosed patent litigation to market a generic version of Ocaliva (obeticholic acid) 5 mg and 10 mg tablets in the USA. Ocaliva is

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/Zu543s8